Preveceutical Medical Inc C.PREV

Alternate Symbol(s): PRVCF

PreveCeutical Medical Inc. is a Canada-based health sciences company. The Company’s principal business activity is the development of options for preventive and curative therapies utilizing organic and nature identical products. The Company’s pipeline includes Cannabinoid Sol-Gel, Non-Addictive Analgesic, BSV Peptide Program and Dual Gene Therapy. Its Cannabinoid Sol-Gel is cannabinoid-based nose-to-brain delivery system that provides relief to a range of indications from pain, inflammation, seizures, and neurological disorders. Its BSV peptide program targets cancer progression. Its Non-Addictive Analgesic is an engineering non-addictive analgesic peptide for pain management. Its Dual Gene Therapy targets type 2 diabetes and obesity. The Company’s subsidiary, PreveCeutical (Australia) Pty Ltd., manages its research programs.

CSE:PREV - Post by User

Preveceutical Medical Inc

Bullboard Posts

Comment by GajjarDron Oct 12, 2018 1:00pm

125 Views

Post# 28789426

RE:OCTOBER 16th 👀

Yes

TheCypher wrote: Will be a pivotal day for us. Keep an eye on the short data, and ears to the ground re: PreveCeutical meeting in Montreal.

www.eventbrite.ca/e/preveceutical-medical-inc-corporate-update-tickets-51099334485

https://shortdata.ca/stock/PREV.CN/

Short volume will be significantly higher than the October 1st 39.5 Million shares traded short. Some have suggested close to 90 Million. A QUARTER of the entire share float. Imaging what will happen when those shorts run for the hills.

The meeting in Montreal will solidify details on the Penta5 acquisition, sealing revenue streams that compete with the largest players in the cannabis space, and that doesn’t begin to scratch the surface of income potential for PreveCeutical Medical. Stephen Van Deventer and his team will be one of the greats. History in the making.

You heard it here.